recombinant interleukin-12
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for recombinant interleukin-12, covering 2017-08-31 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors [Phase 1]